Institutional investors in Emergent BioSolutions Inc. lost 9.5 percent last week but have reaped the benefits of longer-term growth

EBS Stock  USD 8.48  0.21  2.42%   
Slightly above 64% of Emergent Biosolutions' investor base is looking to short. The analysis of the overall investor sentiment regarding Emergent Biosolutions suggests that many traders are alarmed. Emergent Biosolutions' investing sentiment can be driven by a variety of factors including economic data, Emergent Biosolutions' earnings reports, geopolitical events, and overall market trends.
  
Key Insights Institutions substantial holdings in Emergent BioSolutions implies that they have significant influence...

Read at simplywall.st
Simply Wall St News at Macroaxis
  

Emergent Biosolutions Current Investor Sentiment

Panic Vs Confidence

36

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Emergent Biosolutions' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Emergent Biosolutions.

Emergent Biosolutions Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Emergent Biosolutions can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Emergent Biosolutions Historical Investor Sentiment

Investor biases related to Emergent Biosolutions' public news can be used to forecast risks associated with an investment in Emergent. The trend in average sentiment can be used to explain how an investor holding Emergent can time the market purely based on public headlines and social activities around Emergent Biosolutions. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Emergent Biosolutions' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Emergent Biosolutions and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Emergent Biosolutions news discussions. The higher the estimate score, the more favorable the investor's outlook on Emergent Biosolutions.

Emergent Biosolutions Fundamental Analysis

We analyze Emergent Biosolutions' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emergent Biosolutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emergent Biosolutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Emergent Biosolutions is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Emergent Biosolutions Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Emergent Biosolutions stock to make a market-neutral strategy. Peer analysis of Emergent Biosolutions could also be used in its relative valuation, which is a method of valuing Emergent Biosolutions by comparing valuation metrics with similar companies.

Peers

Emergent Biosolutions Related Equities

CPIXCumberland Pharmaceuticals   23.85   
0%
100.0%
DRRXDurect   1.30   
0%
5.0%
BHCBausch Health   0.39   
0%
1.0%
COLLCollegium Pharmaceutical   0.17   
0%
1.0%
NBIXNeurocrine Biosciences   0.51   
2.0%
0%
ALKSAlkermes Plc   0.66   
2.0%
0%
ZTSZoetis   0.69   
2.0%
0%
ITCIIntracellular   1.12   
4.0%
0%
LFCRLifecore Biomedical   1.32   
5.0%
0%
PBHPrestige Brand   1.39   
5.0%
0%
AKANAkanda Corp   3.23   
13.0%
0%

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.